Recent analysis by Silico Research has found that senior life science executives in companies based in the Asia-Pacfic region are more positive about the prospects for strategic alliances with large pharmaceutical and biotechnology companies. Of the top six countries in terms of attitude to strategic alliances five were from the Asia-Pacific region. Of the bottom six counties in terms of attitude to strategic alliances not a single one was from the Asia-Pacific region.
Respondents from China were the most positive about strategic alliances and partners (91% net positive rating) compared to, for example, respondents from the United States (50%) and Switzerland (34%).
On all important issues covered by the BioPartnering core surveys respondents from the Asia-Pacific region are significantly more positive than respondents from Europe or North America (n=2,824).
The difference between respondents from the Asia-Pacific region and the rest of the world was particularly pronounced in terms of the respondent's attitude to the other company's responsiveness (74% difference) and the other company's problem-solving abilities (58% difference).
Overall there was little or no difference in the attitude of respondents to companies in the same country as themselves and companies in different countries.
Equally, there was no difference in the attitude to partners and partnering of respondents in the smokestack states north-eastern region of the United States (48% net positive rating) and the western states (47%).